Progress Toward Regional Measles Elimination — Worldwide, 2000–2021

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Minta, Anna A. ; Ferrari, Matt ; Antoni, Sebastien ; Portnoy, Allison ; Sbarra, Alyssa ; Lambert, Brian ; Hauryski, Sarah ; Hatcher, Cynthia ; Nedelec, Yoann ; Datta, Deblina ; Ho, Lee Lee ; Steulet, Claudia ; Gacic-Dobo, Marta ; Rota, Paul A. ; Mulders, Mick N. ; Bose, Anindya S. ; Perea, William A. ; O’Connor, Patrick
• Description:
  All six World Health Organization (WHO) regions have committed to eliminating measles.* The Immunization Agenda 2021-2030 (IA2030)| aims to achieve the regional targets as a core indicator of impact and positions measles as the tracer of a health system's ability to deliver essential childhood vaccines. IA2030 highlights the importance of ensuring rigorous measles surveillance systems to document immunity gaps and achieve 95% coverage with 2 timely doses of measles-containing vaccine (MCV) among children. This report describes progress toward measles elimination during 2000-2021 and updates a previous report (1). During 2000-2021, estimated global coverage with a first MCV dose (MCV1) increased from 72% to a peak of 86% in 2019, but decreased during the COVID-19 pandemic to 83% in 2020 and to 81% in 2021, the lowest MCV1 coverage recorded since 2008. All countries conducted measles surveillance, but only 47 (35%) of 135 countries reporting discarded cases| achieved the sensitivity indicator target of two or more discarded cases per 100,000 population in 2021, indicating surveillance system underperformance in certain countries. Annual reported measles incidence decreased 88% during 2000-2016, from 145 to 18 cases per 1 million population, then rebounded to 120 in 2019 during a global resurgence (2), before declining to 21 in 2020 and to 17 in 2021. Large and disruptive outbreaks were reported in 22 countries. During 2000-2021, the annual number of estimated measles deaths decreased 83%, from 761,000 to 128,000; an estimated 56 million measles deaths were averted by vaccination. To regain progress and achieve regional measles elimination targets during and after the COVID-19 pandemic, accelerating targeted efforts is necessary to reach all children with 2 MCV doses while implementing robust surveillance and identifying and closing immunity gaps to prevent cases and outbreaks.
• Subjects:
  Child COVID-19 Disease Eradication Humans Immunization Programs Measles Measles Vaccine Pandemics
• Source:
  MMWR Morbidity Mortal Weekly Rep. 71(47):1489-1495
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.mm7147a1
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  36417303
• Pubmed Central ID:
  PMC9707362
• Document Type:
  Journal Article
• Pages in Document:
  7 pdf pages
• Volume:
  71
• Issue:
  47
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:f9ae44e96ef1d8f889e75161764e111b24747667b250855e39c4c4abfcb9a5e229317b30847b61b325ddbb12047d20a556b3aaf88a7a4f1ae3ec16b12b1e3ed6
• Download URL:
  https://stacks.cdc.gov/view/cdc/123153/cdc_123153_DS1.pdf
• File Type:
  [PDF - 199.45 KB ]